跳至主要内容
临床试验/IRCT20200511047396N1
IRCT20200511047396N1招募中3 期

Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patients

CinnaGen company0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Patients who have Covid-19 based on the CT-scan or RT-PCR findings
  • Hospitalized patients
  • Willingness to participate in the study for trial period and signing the informed consent form
  • Age between 20-65

排除标准

  • Breastfeeding
  • Use of ARB/ACEi
  • History of hypotension
  • have no consent to participate in the study
  • Allergic sensitivity to the interferon products
  • Not availability of phone number or it is possible to be transferred to other hospitals
  • Having the CKD or patients who need dialysis at the begining of the study
  • Having any disease or condition that based on the physician judgment cannot participate in the study
  • Participation in any other trials of Covid-19

研究者

相似试验

Efficacy evaluation of inhalation therapy (nasal... | 临床试验